The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.

1Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China. 2China-US (Henan) Hormel Cancer Institute, Zhengzhou, China. 3Tianjian Laboratory of Advanced ...

State Key Laboratory for Oncogenes and Related Genes, Division of Gastroenterology and Hepatology, Shanghai Cancer Institute, Shanghai Institute of Digestive Disease, Renji Hospital, School of ...

2021年7月8日，中国医科大学附属盛京医院妇产科的Rui Hou(第一作者) & 超声科的Luo Jiang(通讯作者)在Cancer Cell International(中科院二区 IF=5.3)期刊上在线发表题为"LINC00115 ...

TIL therapy uses a patient's own T cells, expanded in vitro, to target cancer cells, offering a personalized treatment approach. Amtagvi (lifileucel) is the first FDA-approved TIL therapy for advanced ...

Limbal stem cell deficiency (LSCD) is a severe ocular condition where the loss of functioning adult stem cells at the cornea's edge leads to vision impairment due to the invasion of fibrotic ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

School of Medicine, Nankai University, Tianjin 300071, P. R. China Department of Orthopedic Surgery, Institute of Orthopedics, The Fourth Medical Center of Chinese PLA General Hospital; Beijing Key ...

[2]近两年，传统的天然草本原料灵芝、枸杞逐渐被现代消费者所接受，被喻为“超级灵芝”的酵母β-葡聚糖及各种新兴免疫增强原料也迎来了明显 ...